VCEL
Vericel Corporation · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +18.4% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | +1 | 33.10M | $1.47B | +8 | −7 |
| Q1 2026 | 101 | +5 | 32.45M | $1.04B | +9 | −4 |
| Q4 2025 | 96 | +4 | 34.49M | $1.24B | +4 | — |
| Q3 2025 | 17 | +1 | 19.50M | $613.54M | +2 | −1 |
| Q2 2025 | 13 | -2 | 17.99M | $765.41M | — | −2 |
| Q1 2025 | 12 | 0 | 5.43M | $242.28M | +1 | −1 |
| Q4 2024 | 12 | 0 | 5.41M | $297.03M | +1 | −1 |
| Q3 2024 | 11 | 0 | 2.16M | $91.36M | — | — |
| Q2 2024 | 11 | — | 1.70M | $78.09M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 2.40M | — | $132.04M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.29M | +119.3% | $70.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.29M | +119.3% | $70.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.29M | +119.3% | $70.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.29M | +119.3% | $70.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.29M | +119.3% | $70.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 1.17M | +1.1% | $64.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passive) | 1.17M | +1.1% | $64.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 170.50K | +16.3% | $9.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 89.50K | +11.5% | $4.91M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 81.37K | +93.2% | $4.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 75.47K | +227.9% | $4.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 71.80K | New | $3.94M | 0.0% | New | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 29.48K | -2.9% | $1.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 13.66K | +0.1% | $750,235 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 9.51K | 0.0% | $522,194 | 0.0% | Held | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 8.18K | -88.1% | $449,108 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 8.18K | -88.1% | $449,108 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $3.94M | 0.0% |
Exited
| AQR Capital Management | $254,726 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 278 holders, 55.09M shares, $1.70B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 7.00K sh · $311,710
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology